Biomed-Lublin。発行体に関する情報。(LEI 259400OWZM67D079S374)。ニュースおよび信用格付。会計および財務報告書を含むテーブル。
ヒントモードがオンになっています オフ
セクション間の迅速なナビゲーションのため

Biomed-Lublin
LEI 259400OWZM67D079S374

組織名
Biomed-Lublin
国名
ポーランド
登録国
ポーランド
業種
製薬準備およびバイオテクノロジー
債券債務
-

最も包括的なデータベースを探索

1 000 000

債券

80 234

161 443

ETF&投資信託

70 000

インデックス

最も効率的な方法でポートフォリオを追跡

  • 債券検索
  • ウォッチリスト
  • Excelアドイン

最新データ

クオート

リクエストを送信
アクセスが拒否されました
情報プロバイダーから提供される引用符は参考値となります

プロフィール

The current employment level in the company amounts to approximately 230 persons (mostly partners). The staff are well qualified specialists, with many years of experience in manufacturing. However, the company welcomes young people and each year new people successfully complete the recruitment process. Our own technologies are mostly applied in manufacturing. In the course of over 60 years of operation “Biomed” has become specialized in the manufacturing of many desirable therapeutic preparations, valued for many years both by doctors and patients. The company follows the idea “Your health is most important for us” and it was adopted as its own mission statement. The main range of the company's activity is the national pharmaceutical market. Besides that the company registers the produced preparations in several European and Asian countries. The products comply with all quality requirements concerning pharmaceuticals. “Biomed” is a holder of the GMP certificate and certificates of free trade. As well as manufacturing activity, it also carries out scientific activity, and has started and maintains cooperation with numerous research centres and independent institutes in Poland and abroad.

受賞歴

ドキュメント

株式

最新の発行体

通貨別公的債務

コード

  • LEI
    259400OWZM67D079S374
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
登録 is required アクセスを得るために必要です。